The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

Two people killed and 22 injured after Mexican training ship crashes into Brooklyn Bridge ‘The Plague' Review: Joel Edgerton in a Thrilling Drama That Captures the ...